Make your scheduling
- All Posts
- Sem categoria
1 – I have products registered in the name of my distributor or even in the name of acompany that...
In the current context of Brazilian public health, the effective detection and monitoring of notifiable diseases such as Dengue, HIV,...
Navigating regulatory complexities in Brazil is a challenge for many companies, especially those operating in the healthcare field. In this...
ANVISA’s Regulatory Agenda is a fundamental pillar for predictability and the evolution of the regulatory environment in Brazil. Its relevance...
Updates in Medical Device Regulation! Today, on December 11, 2023, RDC 830/2023 was published in the Official Gazette, introducing significant...
“In 2023, the medical devices industry faces significant environmental challenges. The environmental impact of the healthcare sector as a whole...
🤝🔬 The collaboration between Anvisa (National Health Surveillance Agency) and ANMAT (National Administration of Drugs, Foods, and Medical Technology) is...
In March 2023, China took a significant step on the international stage by joining the Hague Convention. A decision that...
